Back to FDA Applications sponsored by ALCON PHARMS LTD

FDA Drug Application 022212 by ALCON PHARMS LTD

Application Number022212
Application Type New Drug Application
Sponsor ApplicantALCON PHARMS LTD
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP06/23/2008N20055000 6/24/2008
AP06/23/2008N20056000 6/24/2008
AP06/23/2008N20293000 7/25/2008
AP06/23/2008N20294000 7/25/2008
AP03/20/2009SLR22106001 3/25/2009
AP06/13/2012SE132914003 6/15/2012
AP06/13/2012SE132934003 6/18/2012
AP011/27/2012SCM34478010 11/28/2012
AP011/27/2012SCM34577010 12/10/2012
AP03/22/2013SE835513011 3/26/2013
AP03/22/2013SE835544011 3/26/2013
AP05/15/2013SLR36082012 5/16/2013
AP05/15/2013SLR36108012 5/21/2013
AP07/29/2016SLR46700016 8/2/2016
AP07/29/2016SLR46708016 8/2/2016

Back to FDA Applications sponsored by ALCON PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.